DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Shigeta K, Hasegawa H, Okabayashi K, Tsuruta M, Ishii Y, Endo T. et al.
Randomized phase II trial of TEGAFIRI (tegafur/uracil, oral leucovorin, irinotecan) compared with FOLFIRI (folinic acid, 5-fluorouracil, irinotecan) in patients with unresectable/recurrent colorectal cancer.
Int J Cancer 2016;
139: 946-54
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.